OBJECTIVE: To explore the effect of reinforced health education on deep radiofrequency thermotherapy for patients with tumor. METHODS: From June 2012 to June 2014, 106 patients who underwent deep radiofrequency thermotherapy in our hospital were randomly selected, and were divided into a control group (n=69) and an observation group (n=65). The observation group received reinforced health education while the control group received the traditional health education before treatment. Th e reinforced health education included preparation, cooperation and health behavior during and aft er treatment. Th en the compliance rate, degree of satisfaction, and the awareness rate of related knowledge were compared and analyzed aft er treatment between the 2 groups. RESULTS: Th e compliance rate in the observation group and the control group was 85.51% and 63.08% respectively; there was significant difference in the awareness rates of related knowledge and the overall degree of satisfaction between the patients and their family members (all P<0.05). CONCLUSION Implement of reinforced health education is benefit to patients to understand the content of health education before treatment and keep health behavior after treatment, and can also improve the compliance, the degree of satisfaction in the deep radiofrequency thermotherapy for patients with tumor.
Humans ; Hyperthermia, Induced ; Neoplasms ; therapy ; Patient Compliance ; Patient Education as Topic

Depression is one of the prevalent causes of health-related human suffering and is,first and foremost,a disorder of one of the least-studied biological phenomena:emotion.Therefore,it is critically important to understand emotion,in order to understand the etiology of depression.Chinese medicine is the oldest subject about emotion,has developed a theory about basic emotions and their interactions,and also their roles in causes and therapy in most of human diseases,including mental disorders,such as depression.Nowadays,major depressive disorder (MDD) is a prevalent mental disorder with cognitive,affective and behavioral symptoms,and has been identified as a leading cause of disability,and affecting about ～17％ of the populations worldwide.Decades of animal and clinical studies have pointed its etiology in dysfunctions in the monoamine transporters.Here we will review some literatures about the relationship between the monoamine neuromodulators and emotional theory in Chinese medicine,which might introduce theoretical perspectives in studies about emotion and depression.

OBJECTIVE To mine the adverse drug event （ADE） signals of selinexor， and to provide reference for its clinical safety medication. METHODS ADE data for selinexor reported from July 3rd， 2019 to March 31st， 2023 were collected from the FDA adverse event reporting system （FAERS）. Data mining was performed by using the reporting odds ratio （ROR） and proportional reporting ratio （PRR） methods， and categorization statistics were performed by using the system organ class （SOC） and preferred term （PT） from drug ADE terminology set in the MedDRA （version 26.0）. RESULTS A total of 3 084 ADE reports were obtained for selinexor， with a total of 134 ADE-positive signals. Among the reported genders， there were 127 males and 124 females， with a predominant age of ≥65 years old （4.12%）； the United States had the highest number of reports （96.53%）， with consumers being the main reporters （77.27%）； severe ADR was mainly characterized by hospitalization/prolonged hospitalization （26.26%）， followed by death （17.15%）. The top 3 ADE in the list of frequency were nausea （1 162 times）， fatigue （790 times） and anorexia （610 times）， all of which were mentioned in the selinexor’s instructions. The top 3 signals in the list of strength were device-associated bacteremia （ROR＝115.07， PRR＝114.94）， blepharospasm dysfunction （ROR＝106.70， PRR＝106.54）， and salmonella sepsis （ROR＝99.90， PRR＝99.81）， all of which were not mentioned in the selinexor’s instructions. CONCLUSIONS In addition to the ADE of nausea mentioned in the instruction manual， attention should also paid to device-associated bacteremia， blepharospasm dysfunction， salmonella sepsis， and other ADE not mentioned in the instruction manual when using selinexor in clinical practice； weekly rechecking of the patient’s blood routine should be done to monitor the patient’s blood indexes， symptoms of infection， and so on， to ensure that the safety of 1661962346@qq.com drug use.